These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1408134)

  • 1. Analysis of temperature-sensitive functions of Fos: lack of a correlation between transformation and TRE-dependent trans-activation.
    Jooss K; Müller R
    Oncogene; 1992 Oct; 7(10):1933-9. PubMed ID: 1408134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple regions of v-Fos protein involved in the activation of AP1-dependent transcription: is trans-activation crucial for transformation?
    Lucibello FC; Neuberg M; Jenuwein T; Müller R
    New Biol; 1991 Jul; 3(7):671-7. PubMed ID: 1751449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
    Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
    Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
    Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W
    Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface Ig receptor-induced nuclear AP-1-dependent gene expression in B lymphocytes.
    Chiles TC; Rothstein TL
    J Immunol; 1992 Aug; 149(3):825-31. PubMed ID: 1634770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AP-1 (Fos-Jun) regulation by IP-1: effect of signal transduction pathways and cell growth.
    Auwerx J; Sassone-Corsi P
    Oncogene; 1992 Nov; 7(11):2271-80. PubMed ID: 1437149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
    Zhang Y; Feng XH; Derynck R
    Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
    Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D
    J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
    Wu WS; Lin JK; Wu FY
    Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells.
    Frisch SM; Reich R; Collier IE; Genrich LT; Martin G; Goldberg GI
    Oncogene; 1990 Jan; 5(1):75-83. PubMed ID: 2157183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells.
    Yukimasa N; Isobe K; Nagai H; Takuwa Y; Nakai T
    Neuropeptides; 1999 Dec; 33(6):475-82. PubMed ID: 10657527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation and transformation by chimaeric Fos-estrogen receptor proteins: altered properties as a consequence of gene fusion.
    Schuermann M; Hennig G; Müller R
    Oncogene; 1993 Oct; 8(10):2781-90. PubMed ID: 8378087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH; Chen TK; Birrer MJ
    Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential and antagonistic effects of v-Jun and c-Jun.
    Gao M; Morgan I; Vogt PK
    Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
    Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR
    Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.